EU-India negotiations on FTA pose a serious threat to access to affordable medicines in the developing world Negotiations on the intellectual property (IP) provisions in the EU–India free trade agreement, of which a round is taking place this week in Brussels, are cause for real concern as… HAI Admin 26 April 2010
Patient Groups need dose of transparency The European Medicines Agency (EMA)’s guidelines on conflicts of interest disclosure for patient and consumer groups are an essential tool to evaluate real or perceived conflicts of interest with the… HAI Admin 26 April 2010
EU lobby transparency book launch by ALTER-EU ALTER-EU launches “Bursting the Brussels Bubble” – a valuable too for anyone concerned with decision-making and democratic accountability within the European Union. Five years ago the European Transparency Initiative was… HAI Admin 26 April 2010
LAC-EU Alliance for Access to Medicines welcomes compulsory license by Ecuadorian Government Quito, 21st April. Various experts and civil society organisation that came together in a meeting of the Latin American and Caribe and European Alliance for Access to Medicines, positively evaluated… HAI Admin 23 April 2010
Roundtable on ACTA by TACD On April 21, 2010, an official version of the consolidated negotiating text of the proposal Anti-Counterfeiting Trade Agreement (ACTA) was published. Next Wednesday, April 28, 2010, the Trans-Atlantic Consumer Dialogue… HAI Admin 23 April 2010
Generic prescribing policies 1 – ABPI 0 The Association of the British Pharmaceutical Industry (ABPI) has lost a legal battle against schemes promoted by Britain’s state health service that encourage doctors to prescribe cheaper medicines. The European… HAI Admin 22 April 2010
Snooping CEO unveils conflicts of interest at the European Medicines Agency Conflict of interest disclosure is essential if transparency is to be achieved. Yet, recent research from Corporate Europe Observatory has revealed loopholes at the European Medicines Agency. The forms used… HAI Admin 21 April 2010
Where to find ACTA Draft Negotiating Text Today, the draft negotiating text for the Anti-Counterfeiting Trade Agreement (ACTA) was published. However, for those finding it difficult to locate the draft text document, please find the link below:… HAI Admin 21 April 2010
EU Global Health Communication The Global Health Communication that came out on April 1st contains some good language on Innovation & Access. However it also contains an worrying reference to IMPACT in the policy… HAI Admin 2 April 2010
Patient advocacy groups: another tool to boost compliance? Andrew Tolve writes that patient groups are yet another means to provide the education and support needed to boost adherance. The full article is reported by Eye for Pharma on… HAI Admin 30 March 2010
Finnish study: Drug companies see added value of patient group sponsorship Finnish researchers E. Hemminki, H.K. Toiviainen, and L. Vuorenkoski reported that drug companies see patient group sponsorship as a means to inform patients about their products and to move their… HAI Admin 29 March 2010
No NGO briefings will be allowed during World Health Assembly this year. No NGO briefings will be allowed during World Health Assembly this year. This decision by the WHO is very concerning as this cuts off the main way for civil society… HAI Admin 29 March 2010
HAI Response: ACTA Stakeholders Meeting in European Parliament ACTA is increasingly controversial and public outcry is swelling. See HAI’s contribution to EU stakeholders meeting March 22. ”ACTA is not about public health but will hurt it” HAI Admin 29 March 2010